首页|期刊导航|中华医学杂志(英文版)|Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type Ⅱ as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis
Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type Ⅱ as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis
ZHAO Dong-bing Ian Chandler CHEN Zheng-ming PAN Hong-chao Sanjay Popat SHAO Yong-fu Richard S Houlston
中华医学杂志(英文版)2011,Vol.124Issue(4):483-490,8.
中华医学杂志(英文版)2011,Vol.124Issue(4):483-490,8.DOI:10.3760/cma.j.issn.0366-6999.2011.04.001
Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type Ⅱ as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis
Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type Ⅱ as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis
摘要
Abstract
Background The expression of genes encoding a number of pathogenetic pathways involved in colorectal cancer could potentially act as prognostic markers. Large prospective studies are required to establish their relevance to disease prognosis.Methods We investigated the relevance of 19 markers in 790 patients enrolled in a large randomised trial of 5-fluorouracil using immunohistochemistry and chromogenic in situ hybridisation. The relationship between overall 10-year survival and marker status was assessed.Results Minichromosome maintenance complex component 2 (MCM2) and cyclin A were significantly associated with overall survival. Elevated MCM2 expression was associated with a better prognosis (HR=0.63, 95%CI: 0.46-0.86).Cyclin A expression above the median predicted an improved patient prognosis (HR=0.71, 95%CI: 0.53-0.95). For mismatch repair deficiency and transforming growth factor β receptor type Ⅱ (TGFBRII) overexpression there was a borderline association with a poorer prognosis (HR=0.69, 95%C/: 0.46-1.04 and HR=2.11, 95%CI: 1.02-4.40,respectively). No apparent associations were found for other markers.Conclusion This study identified cell proliferation and cyclin A expression as prognostic indicators of patient outcome in colorectal cancer.关键词
colorectal cancer/tissue microarray/immunohistochemistry/prognostic markersKey words
colorectal cancer/tissue microarray/immunohistochemistry/prognostic markers引用本文复制引用
ZHAO Dong-bing,Ian Chandler,CHEN Zheng-ming,PAN Hong-chao,Sanjay Popat,SHAO Yong-fu,Richard S Houlston..Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type Ⅱ as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis[J].中华医学杂志(英文版),2011,124(4):483-490,8.基金项目
This work was supported by grants from Cancer Research UK and the Association for International Cancer Research. Ian Chandler was in receipt of a Clinical Research Fellowship grant from St.George's Hospital Charitable Foundation Medical Research Committee. ()